Summary In the adoptive immunotherapy for cancer, the amounts of induced effector cells play a major role in improving therapeutic efficacy. We have already demonstrated that interleukin 4 (IL-4) augments proliferation of tumour-infiltrating lymphocytes (TILs) without altering the cytotoxic activity against autologous tumour cells. The present study is designed to investigate how IL-4 augments TILs by using established TIL clones in terms of IL-2/IL-2 receptor system. CD4+, CD8+ and CD4+CD8+ (double positive) TIL clones were established from cancer patients. At clonal level, IL-4 augmented the proliferation of IL-2-activated TIL clones irrespective of phenotypes. In order to clarify the mechanism of IL-4 at clonal level, the blocking assay by anti-IL-2 receptor a and P chain and binding assay of IL-2 on the cell surface and the measurement of the internalisation of IL-2 in the cell were performed. It was clarified that IL-4 up-regulated the IL-2 receptor and then augmented the action of IL-2 molecule on the cell surface stimulated by IL-4. Furthermore, binding IL-2 internalised rapidly into the cells. Thus, it is suggested that signal transduction is augmented and proliferation of TILs is enhanced by IL-4 via the action of IL-2/IL-2 receptor system. Keywords: interleukin 4; tumour-infiltrating lymphocyte; interleukin-2 receptor; scathard analysis Adoptive immunotherapy (AIT) using tumour-infiltrating lymphocytes (TILs) has been carried out by various investigators (Rosenberg et al., 1986; Topalian et al., 1988; Yamaue et al., 1990) . The number of transferred TILs is a critical factor for obtaining a therapeutic effect. Interleukin 4 (IL-4) is a pleiotrophic cytokine that acts on various cell types (Paul and O'Hara, 1987; Swain et al., 1988; Spits et al., 1987; Horohov et al., 1988; Mitchell et al., 1989) , and is produced by helper T cell type 2 (Mosmann et al., 1986) . It has been reported that IL-4 mainly acts on B cells (BCGF, Bcell growth factor) (Howard et al., 1982) , and that it can augment the cytotoxic activity of lymphokine-activated killer (LAK) cells in a murine model (Mule et al., 1987) . Recently, it has been demonstrated that IL-4 inhibited LAK activity in humans (Nagler et al., 1988) . However, it has been reported that IL-4 enhanced the proliferation of TILs obtained from different types of human tumours (Kawakami et al., 1988 (Kawakami et al., , 1993 . We have previously demonstrated that IL-4 augments the proliferation of interleukin 2 (IL-2)-activated TILs without inhibiting their cytotoxic activity against autologous tumour cells. Thus, the combination of IL-2 with IL-4 may lead to improved therapeutic efficacy of AIT using TILs (Tsunoda et al., 1992a) . However, the mechanism of IL-4 on the augmentation of proliferation about TILs has not been clarified yet. In the present study, we demonstrated that the functional mechanism of IL-4 was clarified under clonal level.
Adoptive immunotherapy (AIT) using tumour-infiltrating lymphocytes (TILs) has been carried out by various investigators (Rosenberg et al., 1986; Topalian et al., 1988; Yamaue et al., 1990) . The number of transferred TILs is a critical factor for obtaining a therapeutic effect. Interleukin 4 (IL-4) is a pleiotrophic cytokine that acts on various cell types (Paul and O'Hara, 1987; Swain et al., 1988; Spits et al., 1987; Horohov et al., 1988; Mitchell et al., 1989) , and is produced by helper T cell type 2 (Mosmann et al., 1986) . It has been reported that IL-4 mainly acts on B cells (BCGF, Bcell growth factor) (Howard et al., 1982) , and that it can augment the cytotoxic activity of lymphokine-activated killer (LAK) cells in a murine model (Mule et al., 1987) . Recently, it has been demonstrated that IL-4 inhibited LAK activity in humans (Nagler et al., 1988) . However, it has been reported that IL-4 enhanced the proliferation of TILs obtained from different types of human tumours (Kawakami et al., 1988 (Kawakami et al., , 1993 . We have previously demonstrated that IL-4 augments the proliferation of interleukin 2 (IL-2)-activated TILs without inhibiting their cytotoxic activity against autologous tumour cells. Thus, the combination of IL-2 with IL-4 may lead to improved therapeutic efficacy of AIT using TILs (Tsunoda et al., 1992a) . However, the mechanism of IL-4 on the augmentation of proliferation about TILs has not been clarified yet. In the present study, we demonstrated that the functional mechanism of IL-4 was clarified under clonal level.
Materials and methods
Culture media and tumour cell lines Recombinant human IL-2 (Shionogi Pharmaceutical Co., Japan) and recombinant human IL-4 (Ono Pharmaceutical Co., Japan) were used for cell stimulation. RPMI-1640 medium (Gibco, Grand Island, NY, USA) was supplemented with 10% heat-inactivated human AB serum obtained from healthy subjects, 100 U ml-' penicillin, 100 pg mlstreptomycin, 2.5 pg ml-1 amphotericin B, 2 mmol 1-1 glutamine and 25 mmol 1-l Hepes (complete medium).
Separation of TILs and autologous tumour cells TILs were separated as previously described (Yamaue et al., 1990; Tsunoda et al., 1992b) . In brief, malignant fluids were obtained from cancer patients and centrifuged. The cell pellets were washed twice and resuspended with complete medium. Cells were then layered onto Ficoll -Hypaque gradients and centrifuged at 400 g for 30 min at 20'C. The interface fraction was collected, washed and resuspended in complete medium, and layered onto discontinuous gradients of 70% and 100% Ficoll-Hypaque. After centrifugation at 400 g for 30 min, the TILs were concentrated at the 100% interface, and the tumour cells were concentrated at the 70% interface. The purity of lymphocytes in the TIL-rich fraction was 60-85%, and this fraction was used as the source of TILs. The tumour cell-rich fraction was contaminated by mesothelial cells and mononuclear cells. To eliminate these cells, the fraction was layered onto discontinuous gradients composed of 4 ml each of 20%, 15% and 10% Percoll (Pharmacia) in complete medium in 15 ml plastic tubes, and then centrifuged at 25 g for 7 min at 20°C. Tumour cells depleted of lymphocytes were collected from the bottom of each tube, washed and resuspended in complete medium. The purity of the tumour cells was usually more than 90% after this extra centrifugation procedure. Freshly isolated tumour cells were over 95% viable according to the trypan blue dye exclusion test, and only cell fractions having less than 10% contamination by non-malignant cells were accepted for use.
Cloning method TIL clones were established by limiting dilution method (Iwahashi et al., 1993) . Briefly, maintained phase TILs were seeded in 96-well U-bottom plates at 0.7 cells per well in 0.2 ml of complete medium containing 105 allogenic peripheral blood mononuclear feeder cells which were treated with 50 pg ml-' Mitomycin C (Kyowa Hakko, Japan) for 30 min at 370C. IL-2 (1500 U ml-') and optimal IL-4 (250 pg ml-' or 2.5 ng ml-') were used for stimulation DNA synthesis TIL clones were cultured in triplicate in round-bottomed microtitre plates with 1500 IU ml-' IL-2 and/or IL-4 (250 ig ml-' or 2.5 ng ml-') at 37°C. After 80 h, 1 ,uCi of [3H]thymidine [3H]TdR, New England Nuclear, Boston, USA) was added to each well and culture was continued for an additional 16 h. Samples were harvested using a cell harvester (Cambridge Technology, Cambridge, MA, USA) and the amount of incorporated radioactivity was measured using a liquid-scintillation counter.
IL-2 receptor blocking assay
Anti-CD25 antibody (anti-IL-2 receptor a chain, 10 Mug ml-', CosmoBio, Tokyo, Japan) and TU27 (anti-IL-2 receptor ,B chain, 50 jug ml-', kindly provided by Dr Sugamura, Tohoku University, Japan) were used for IL-2 receptor blocking assay (Yagita et al., 1989) . The concentrations used have been sufficiently proved for inhibition in the proliferation of T cells by preliminary studies. Inhibition of DNA synthesis was used to measure receptor blocking.
IL-2 binding assay and Scatchard analysis IL-2 binding assay was performed by modified Robb's method as previously described (Robb et al., 1984) . In brief, cells were washed three times in complete medium and incubated for 6 h at 37°C to remove IL-2. After an additional wash, the cells were resuspended in the same medium. Shimizu et Whitford et al., 1990; Viale et al., 1990) have not observed a subpopulation of double-positive T cells in TILs. In our system, IL-4 was used to establish TIL clones and it was thought that IL-4 augments the expression of the CD8 molecule in CD4+ T cells (Paliard et al., 1988) . This might be the reason why we could establish double-positive T-cell clones. The cytokine production of these TIL clones was measured. IL-I, IFN-y and TNFcx were produced from these TIL clones (data not shown). It may be indicated that IL-4 augments the cytokine network system (Lorre et al., 1990) .
Next, by using three different T-cell clones, proliferation enhanced the proliferation induced with IL-2. In this mechanism, IL-2 and IL-2 receptor system were thought to be crucial (Fernandez-Botran et al., 1989; Kawakami et al., 1989; Ishikawa et al., 1991) . In our studies, a blocking assay using anti-IL-2 receptor x-chain antibody (CD25) and /3-chain antibody (TU27) was performed on representative clones. IL-2 receptor oc chain alone (low affinity) and /B chain alone (intermediate) did not inhibit proliferation in comparison with control antibody. However, simultaneous addition of both IL-2 receptor antibodies inhibited proliferation. Interestingly, the inhibition was similar in clones cultured with IL-2 alone or with IL-2 plus IL-4. It is suggested that the augmentation of IL-4 is related to high-affinity IL-2 receptor. However, cell surface expression of IL-2 receptor achain, /3-chain and IL-4 receptor by these clones was analysed by flow cytometry. There was no difference in receptor expression between cells stimulated with IL-2 alone or IL-2 plus IL-4 (data not shown).
Furthermore, the IL-2 binding assay and Scatchard analysis at clonal level showed that IL-4 did not change the value of Kd of the high-affinity IL-2 receptor (200 pM) and the low-affinity IL-2 receptor (2.8 nM) in comparison with IL-2 alone. These data suggest that IL-4 does not change the functional characteristics of the IL-2 receptor. On the other hand, IL-4 increased the binding amount of IL-2 molecule on the cell surface at both the IL-2 receptors. It is especially important that IL-4 increases the binding of IL-2 on the high-affinity IL-2 receptor, since this receptor is thought to be related to signal transduction (Yagita et al., 1989) . This may be the mechanism for the synergistic effect of IL-4 on proliferation.
The increase of binding IL-2 molecule on TILs exposed to IL-4 prompted us to examine the internalisation of IL-2, which depends on the latter receptor (Fujii et al., 1986; Siegel et al., 1987; Robb et al., 1987; Yoshimoto et al., 1990) . It was found that internalisation of IL-2 was augmented by at the early incubation time points (10 and 30 min). Thus, the enhanced internalisation of IL-2 induced by IL-4 may accelerate delivery signals of transduction that is followed by the heightened proliferation of TILs. The combined effects that IL-4 has on up-regulation of the high-affinity IL-2 receptor, increasing the amount of IL-2 bound per TIL, and enhancement of internalisation of IL-2 together lead to augmentation of TIL proliferation.
Recently, IL-2 receptor y chain has been sequenced and analysed in detail (Takeshita et al., 1992) . High-affinity IL-2 receptor was clarified to consist of a-, f,-and y-chain, and the y-chain was shown to be crucial to signal transduction . Moreover, the IL-2 receptor y-chain has high homology to the IL-4 receptor (Kondo et al., 1993) . IL-2 receptor y-chain may play an important role in the augmentation of TIL proliferation caused by IL-4. We have shown at the clonal level that IL-4 augmented the proliferation of TIL clones via the IL-2 receptor. At present, we are now attempting to analyse the involvement of the IL-2 receptor y-chain in the stimulation of proliferation produced by IL-4.
The expression of IL-4 receptor was analysed by radioimmunoassay. There was no significant difference by stimulation with IL-4 (data not shown). However, it is possible that the phenomena reported reflect some inside-out modulation of surface IL-2 receptor mediated via the IL-4/ IL-4 receptor system.
